Avanos Medical (AVNS) Change in Receivables (2013 - 2026)

Avanos Medical has disclosed Change in Receivables across 14 years of filings, most recently posting $300000.0 for Q1 2026.

• In Q1 2026, Change in Receivables rose 101.2% year-over-year to $300000.0; the TTM figure through Mar 2026 stood at -$5.5 million (up 46.6% YoY), while the FY2025 annual figure was -$30.9 million, down 568.18% from the prior year.
• Change in Receivables came in at $300000.0 for Q1 2026 at Avanos Medical, up from -$8.1 million in the prior quarter.
• In the past five years, Change in Receivables ranged from a high of $18.7 million in Q4 2022 to a low of -$26.2 million in Q1 2023.
• Average Change in Receivables over 5 years is -$2.3 million, with a median of -$700000.0 recorded in 2025.
• Year-over-year, Change in Receivables jumped 6133.33% in 2022 and plunged 2600.0% in 2025.
• Over 5 years, Change in Receivables stood at $18.7 million in 2022, then tumbled by 148.13% to -$9.0 million in 2023, then jumped by 96.67% to -$300000.0 in 2024, then sank by 2600.0% to -$8.1 million in 2025, then surged by 103.7% to $300000.0 in 2026.
• Per Business Quant data, the three most recent Change in Receivables figures were $300000.0 in Q1 2026, -$8.1 million in Q4 2025, and -$700000.0 in Q3 2025.